Sickle Cell Pain: Intervention With Capsaicin Exposure
Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and feasibility of using high dose topical capsaicin patches
for the treatment of neuropathic pain in pediatric patients with sickle cell disease, as well
as the feasibility of using a number of tests for the evaluation and monitoring of
neuropathic pain. The hypothesis, based on evidence obtained from studies in adults with
neuropathic pain related to other diseases as well as a single previously published study of
capsaicin in pediatric patients, is that capsaicin will be well tolerated in this population.
Additionally, it is hypothesized that it is feasible to monitor changes in neuropathic pain
via the testing listed below.